Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

So sorry to hear that KarinCA. I agree with your statement about the odds being high for the pancreatic patient having previously failing earlier treatment. I pray Kevetrin can be of use for future pancreatic cancer patients since they typically are diagnosed at an advanced stage (similar to ovarian cancer patients) and the disease is so refractory to the current treatment options. I found it interesting that they mentioned "CEA, was decreased and the tumor size remained stable over 4 months in a pancreatic carcinoma patient" since CA19.9 is the most widely used biomarker for diagnosis of pancreatic cancer. I am not certain if CA19.9 is also the most accurate biomarker for treatment efficacy. It would be interesting if they ran a test for CA19.9 for the pancreatic cancer patient if that is the best biomarker for efficacy of treatment. Ii am sure the researchers have it covered though. I hope future trials include more pancreatic cancer patients to see if Kevetrin can be of benefit. Enjoyed your article today, you are always thorough and illuminating.